Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes

The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies

(2016) Chao Han et al.   PLoS One

Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma

(2014) Jordan M Cloyd et al.   JOURNAL OF SURGICAL ONCOLOGY

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: Over 4 years follow-up

(2014) Francesco Boccardo et al.   MICROSURGERY

Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies

(2013) Takashi Sakurai et al.   JOURNAL OF SURGICAL ONCOLOGY

Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients

(2012) Katsumi Ikeda et al.   World Journal of Surgical Oncology

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Axillary reverse mapping using a fluorescence imaging system in breast cancer

(2011) Miki Noguchi et al.   JOURNAL OF SURGICAL ONCOLOGY

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection

(2010) Takamaru Ashikaga et al.   JOURNAL OF SURGICAL ONCOLOGY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Axillary reverse mapping for breast cancer

(2009) Masakuni Noguchi   BREAST CANCER RESEARCH AND TREATMENT

Estimating the Population Burden of Lymphedema

(2008) Stanley G. Rockson et al.   Annals of the New York Academy of Sciences

Axillary Reverse Mapping: Mapping and Preserving Arm Lymphatics May Be Important in Preventing Lymphedema During Sentinel Lymph Node Biopsy

(2008) Cristiano Boneti et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS